Role of β3-endonexin in the regulation of NF-κB-dependent expression of urokinase-type plasminogen activator receptor

Journal of Cell Science

Volumn 115, Issue 20, 2002, Pages 3879-3888

  Besta, Felicitas ^a   Massberg, Steffen ^a   Brand, Korbinian ^a   Müller, Elke ^a   Page, Sharon ^a   Grüner, Sabina ^a   Lorenz, Michael ^a   Sadoul, Karin ^a   Kolanus, Waldemar ^a   Lengyel, Ernst ^a   Gawaz, Meinrad ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

3 endonexin; 3 integrins; Angiogenesis; NF B; uPAR

Indexed keywords

BETA3 ENDONEXIN; DNA; ENDONEXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX PROTEIN; OLIGONUCLEOTIDE; PROTEIN P50; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; CELL SURFACE RECEPTOR; GREEN FLUORESCENT PROTEIN; ITGB3BP PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOTOPROTEIN; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; PROTEIN; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL ADHESION; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOLYSIS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; STEREOSPECIFICITY; TRANSACTIVATION; ANIMAL; CELL LINE; CELL NUCLEUS; CHO CELL; CYTOLOGY; CYTOPLASM; DOWN REGULATION; DRUG ANTAGONISM; GENE DELETION; GENETIC TRANSCRIPTION; GENETICS; HAMSTER; METABOLISM; MUTATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; BINDING SITES; CELL LINE; CELL NUCLEUS; CHO CELLS; CRICETINAE; CYTOPLASM; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MUTATION; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; UMBILICAL VEINS;

EID: 0037107601     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00081     Document Type: Article

References (42)

1. Allgayer, H., Wang, H., Gallick, G. E., Crabtree, A., Mazar, A., Jones, T., Kraker, A. J. and Boyd, D. D. (1999). Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J. Biol. Chem. 274, 18428-18437.
2. Bianchi, E., Denti, S., Granata, A., Bossi, G., Geginat, J., Villa, A., Rogge, L. and Pardi, R. (2000). Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404, 617-621.
3. Blasi, F. (1999). Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA/u-PAR/PAI-1 system. Thromb. Haemost. 82, 298-304.
4. Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A. and Neumeier, D. (1996). Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest 97, 1715-1722.
5. Chapman, H. A. and Wei, Y. (2001). Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb. Haemost. 86, 124-129.
6. Chen, Q., Kinch, M. S., Lin, T. H., Burridge, K. and Juliano, R. L. (1994). Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 269, 26602-26605.
7. Clark, E. A. and Brugge, J. S. (1995). Integrins and signal transduction pathways: the road taken. Science 268, 233-239.
8. Conese, M. and Blasi, F. (1995). The urokinase/urokinase-receptor system and cancer invasion. Baillieres Clin. Haematol. 8, 365-389.
9. Dedhar, S. and Hannigan, G. E. (1996). Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr. Opin. Cell Biol. 8, 657-669.
10. Dejana, E. (1993). Endothelial cell adhesive receptors. J. Cardiovasc. Pharmacol. 21 Suppl. 1, S18-S21.
11. Eigenthaler, M., Hofferer, L., Shattil, S. J. and Ginsberg, M. H. (1997). A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its specific interaction with beta3-endonexin. J. Biol. Chem. 272, 7693-7698.
12. Ellis, V. (1996). Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase. J. Biol. Chem. 271, 14779-14784.
13. Gawaz, M., Neumann, F. J., Dickfeld, T., Koch, W., Laugwitz, K. L., Adelsberger, H., Langenbrink, K., Page, S., Neumeier, D., Schömig, A. et al. (1998). Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98, 1164-1171.
14. Gawaz, M., Besta, F., Ylänne, J., Knorr, T., Dierks, H., Böhm, T. and Kolanus, W. (2001). The NITY motif of the beta-chain cytoplasmic domain is involved in stimulated internalization of the beta3 integrin A isoform. J. Cell Sci. 114, 1101-1113.
15. Ghosh, G., van Duyne, G., Ghosh, S. and Sigler, P. B. (1995). Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature 373, 303-310.
16. Hapke, S., Gawaz, M., Dehne, K., Kohler, J., Marshall, J. F., Graeff, H., Schmitt, M., Reuning, U. and Lengyel, E. (2001a). beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter. Mol. Cell. Biol. 21, 2118-2132.
17. Hapke, S., Kessler, H., Arroyo de Prada, N., Benge, A., Schmitt, M., Lengyel, E. and Reuning, U. (2001b). Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. J. Biol. Chem. 276, 26340-26348.
18. Hynes, R. O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25.
19. Israel, A. (2000). The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10, 129-133.
20. Karin, M. and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621-663.
21. Kashiwagi, H., Schwartz, M. A., Eigenthaler, M., Davis, K. A., Ginsberg, M. H. and Shattil, S. J. (1997). Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a selective binding partner of the beta3 integrin cytoplasmic tail. J. Cell Biol. 137, 1433-1443.
22. LaFlamme, S. E., Homan, S. M., Bodeau, A. L. and Mastrangelo, A. M. (1997). Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus. Matrix Biol. 16, 153-163.
23. Lengyel, E., Wang, H., Stepp, E., Juarez, J., Wang, Y., Doe, W., Pfarr, C. M. and Boyd, D. (1996). Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J. Biol. Chem. 271, 23176-23184.
24. Li, D., Desai-Yajnik, V., Lo, E., Schapira, M., Abagyan, R. and Samuels, H. H. (1999). NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol. Cell Biol. 19, 7191-7202.
25. Li, D., Wang, F. and Samuels, H. H. (2001). Domain Structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation. Mol. Cell. Biol. 21, 8371-8384.
26. Liotta, L. A., Goldfarb, R. H., Brundage, R., Siegal, G. P., Terranova, V. and Garbisa, S. (1981). Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41, 4629-4636.
27. Liu, S., Calderwood, D. A. and Ginsberg, M. H. (2000). Integrin cytoplasmic domain-binding proteins. J. Cell Sci. 113, 3563-3571.
28. Lund, L. R., Ellis, V., Ronne, E., Pyke, C. and Dano, K. (1995). Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem. J. 310, 345-352.
29. Muller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L. and Harrison, S. C. (1995). Structure of the NF-kappa B p50 homodimer bound to DNA. Nature 373, 311-317.
30. Ohtoshi, A. and Otoshi, H. (2001). Analysis of beta3-endonexin mutants for their ability to interact with cyclin A. Mol. Genet. Genomics 266, 664-671.
31. Ohtoshi, A., Maeda, T., Higashi, H., Ashizawa, S., Yamada, M. and Hatakeyama, M. (2000). beta3-endonexin as a novel inhibitor of cyclin A-associated kinase. Biochem. Biophys. Res. Commun. 267, 947-952.
32. Schwartz, M. A., Schaller, M. D. and Ginsberg, M. H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599.
33. Shattil, S. J., O'Toole, T., Eigenthaler, M., Thon, V., Williams, M., Babior, B. M. and Ginsberg, M. H. (1995). Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J. Cell Biol. 131, 807-816.
34. Shetty, S., Kumar, A. and Idell, S. (1997). Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17, 1075-1083.
35. Soravia, E., Grebe, A., de Luca, P., Helin, K., Suh, T. T., Degen, J. L. and Blasi, F. (1995). A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood 86, 624-635.
36. Tang, S., Gao, Y. and Ware, J. A. (1999). Enhancement of endothelial cell migration and in vitro tube formation by TAP20, a novel beta 5 integrin-modulating, PKC theta-dependent protein. J. Cell Biol. 147, 1073-1084.
37. Urban, M. B. and Baeuerle, P. A. (1991). The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biol. 3, 279-288.
38. Wang, Y., Dang, J., Johnson, L. K., Selhamer, J. J. and Doe, W. F. (1995). Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family. Eur. J. Biochem. 227, 116-122.
39. Wang, Y., Dang, J., Wang, H., Allgayer, H., Murrell, G. A. and Boyd, D. (2000). Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur. J. Biochem. 267, 3248-3254.
40. Willert, K. and Nusse, R. (1998). Beta-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8, 95-102.
41. Xue, W., Mizukami, I., Todd, R. F., III and Petty, H. R. (1997). Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57, 1682-1689.
42. Ylänne, J., Huuskonen, J., O'Toole, T. E., Ginsberg, M. H., Virtanen, I. and Gahmberg, C. G. (1995). Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. J. Biol. Chem. 270, 9550-9557.